Finally, our in vivo study showed that knockdown of LIN28B, PCAT5, and IGF2BP3 could inhibit tumor growth in xenografted tumors, and mice injected with the combination of these three agents showed minimal xenografted tumor volume and weight. Here, LIN28B is linked to neoplasm.